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Sforcibly extracted with the guidewire in 4 lesions; retrieved with the two-guidewire
technique in one lesion; and retrieved after the imaging core was removed in 5 lesions.
In these 5 lesions, (1) we cut only the outer envelope of View IT catheter; (2) removed
the imaging core (3) put the distal part of 0.014 inch coronary guidewire into the
envelope; and (4) pulled the IVUS catheter. Stent deformation was angiographically
observed in 5 lesions (forcibly extracted in 3 lesions, removed the imaging core in 2
lesions), and post stent dilatation was performed in 6 lesions. All patients with IVUS
entrapment were successfully managed percutaneously and discharged without any
other complication including stent thrombosis.
Conclusions: Entrapment of an IVUS catheter was an infrequent complication of PCI.
Removing imaging core was an alternative technique to retrieve an entrapped IVUS
catheter.
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Background: Few studies have assessed outcomes in minorities undergoing percu-
taneous coronary intervention (PCI) for acute coronary syndromes (ACS), and
minorities have traditionally been underrepresented in clinical trials in the drug-eluting
stent era. We therefore sought to compare short- and long-term outcomes between
non-white and white patients undergoing PCI for ACS in the large-scale HORIZONS-
AMI and ACUITY trials.
Methods: Data from 11,126 patients undergoing PCI for STEMI and NSTEACS from
the HORIZONS-AMI and ACUITY trials were pooled. Patients were stratiﬁed by race
(non-white vs. white), and adverse outcomes were assessed with propensity-adjusted
multivariable analysis at 30-day and 1-year time points.
Results: Among the total PCI cohort, 10,128 patients (91%) were white and 998
patients (9.0%) were non-white. Non-white patients were younger, more likely to be
women, diabetic, hypertensive, and to have experienced prior myocardial infarction
and coronary revascularization. When controlling for these and other baseline and
treatment variables through propensity-adjusted multivariable analysis, non-white
patients had comparable risk for hemorrhagic and ischemic events compared with
white race counterparts at 30 days and 1 year (Table).
Conclusions: In this analysis of the large-scale HORIZONS-AMI and ACUITY trials,
non-white patients were younger, but otherwise more likely to present with a number
of comorbidities. After propensity-adjustment, non-white patients experienced similar
short- and long-term rates of adverse events as compared with white patients. Further
studies are indicated to help determine whether differences in outcomes between races
reported in the literature are due to baseline risk factors or disparities in access and
treatment.Table. Propensity-Adjusted Adverse Outcomes by Non-White vs. White
Patients
Non-White
Patients
(N=998)
White Patients
(N=10128)
Adjusted Hazard
Ratio
[95% CI]
Adjusted
p-Value
Thirty-Day Outcomes
Non-CABG major
bleeding
72 (7.3) 618 (6.1) 1.16 [0.84, 1.61] 0.36
Transfusion 41 (4.1) 276 (2.7) 1.18 [0.76, 1.82] 0.46
Retroperitoneal
bleed
10 (1.0) 50 (0.5) 1.30 [0.52, 3.23] 0.58
All-cause death 14 (1.4) 150 (1.5) 1.20 [0.50, 2.94] 0.68
Myocardial
infarction
64 (6.5) 484 (4.8) 1.30 [0.96, 1.75] 0.09
Death or
myocardial
infarction
75 (7.6) 602 (6.0) 1.28 [0.95, 1.72] 0.10
MACE 85 (8.6) 715 (7.2) 1.22 [0.93, 1.61] 0.16
One-Year Outcomes
All-Cause death 39 (4.1) 342 (3.8) 1.35 [0.83, 2.17] 0.23
Myocardial
infarction
90 (9.3) 724 (7.5) 1.19 [0.91, 1.56] 0.21
Death or
myocardial
infarction
121 (12.4) 993 (10.5) 1.19 [0.93, 1.52] 0.16
MACE 167 (17.3) 1506 (15.9) 0.98 [0.79, 1.22] 0.87
Data presented as n (%). CABG ¼ coronary artery bypass graft; CI ¼ conﬁdence interval;
MACE ¼ Major Adverse Cardiovascular Events.
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Background: The risk of contrast-inducednephropathy (CIN) is signiﬁcantly inﬂuenced
by baseline renal function and amount of contrast media (CM). Despite commonly usage
in clinical practice, serum creatinine has signiﬁcant limitations in accuracy. Therefore
we evaluated the usefulness of the cystatin C (CyC) based estimated glomerular ﬁltra-
tion rate (eGFRCyC) in prediction of CIN and to determine safe CM dose.
Methods: We prospectively enrolled a total of 723 patients who received percuta-
neous coronary intervention (PCI) and investigated clinical factors associated with
development of CIN. Renal function was calculated as eGFRCyC and a modiﬁed diet
in renal disease (MDRD) equation, respectively. Systemic exposure of CM was
calculated as CM volume to eGFR ratio. We conducted a regression analysis to
evaluate the predictive role of CM volume to eGFRCyC for risk of CIN.
Results: The incidence of CIN was 4.0% (29/723). The patients with CIN had lower
hemoglobin level, more decreased renal function, and higher CyC value, and greater
CM exposure. On multivariate regression analyses, hemoglobin (Odds ratio (OR)
0.743, p¼0.032), CM volume/eGFRCyC (OR 1.697, p¼0.006) and CM volume/
MDRD (OR 2.275, p<0.001) were found to be independent predictors for CIN. In
receiver operating characteristic curve analysis, fair discrimination for CIN was found
at a CM volume/ eGFRCyC level of 4.493 (C-statics ¼ 0.814), and at this value, the
sensitivity and speciﬁcity were 79.3% and 80.0%, respectively.
Conclusions: Thesedata suggest that aCMvolume/eGFRCyCmethodwouldbea simple,
useful indicator for determining the safe CM-dose based on eGFR value before PCI.
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Background: Stroke is a rare complication from percutaneous coronary intervention
(PCI) and is usually associated with high morbidity and mortality. This study was
conducted to review the contemporary incidence and predictors of peri-procedural
stroke related to PCI.
Methods: A total of 23,117 patients who underwent PCI from 2002 to 2012 in our
center were analyzed.
Results: A total of 64 patients suffered with PCI-related stroke. Overall, the rates of
stroke remained constant over the past 10 years (p¼0.09) with an incidence of peri-
procedural stroke per year of 0.24%  0.15%. Patients with stroke were older (69 
11 vs 65  13 years), were more African American (46.2% vs 28.0%), had more
myocardial infarction during admission (54.7% vs 29.8%), more insulin dependent
diabetes mellitus (41.5% vs 35.9%) and more history of chronic kidney disease (25%
vs 15.3%), compared to those without stroke (all p <0.05). Multivariable logistic
analysis identiﬁed IABP as the strongest predictor for stroke, followed by African
American race, presentation with myocardial infarction and increasing age. (Figure)
For patients with peri-procedural stroke, the in-hospital length of stay was longer (12
 11.3 vs 3.1  4 days, p <0.001) and with higher in-hospital mortality (29.2% vs
1.4%, p <0.001), compared to those without stroke.
Conclusions: The rates for PCI-related stroke were low and have remained stable over
the last decade. However, for complex patients requiring IABP, closer stroke miti-
gation strategies should be considered.er 27–November 1, 2013 j TCT Abstracts/POSTER/PCI Complications
